First Heroes: Engaging Fathers in the First 1000 Days
Status
Conditions
Treatments
Details and patient eligibility
About
The First Heroes study plans to influence weight and health trajectories, modify disease risk, and improve health care services for mother-father-infant triads from racial/ethnic minority and health disparity populations.
This study is a two-arm, randomized controlled trial recruiting from Massachusetts General Hospital (MGH) obstetrics practices. This study will enroll 250 father-mother dyads in the second trimester of pregnancy and intervene through their offspring's 1-year birthday. Each mother-father dyad participating will be randomly assigned to one of two arms: 1. Obstetric and Pediatric Standard of Care + New Parent Engagement Intervention Arm or; 2. Obstetric and Pediatric Standard of Care + Safety Control Arm.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Parental dyads must meet the following criteria:
- Pregnant females and father of the baby, both aged ≥ 18 years
- Singleton pregnancy
- Planned involvement during the first year of the child's life
- Planning to receive post-partum and pediatric care for child at any pediatric practice within the MassGeneral Brigham (Partners) Healthcare system
- Ability to speak in English or Spanish
- Capable of giving consent
Exclusion criteria
- Dyads whose unborn child is found to have a severe defect or comorbidity upon 18-20 week ultrasound.
- Mothers who intend on raising a child alone without any participation from the father of the child.
Trial design
Primary purpose
Allocation
Interventional model
Masking
657 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal